BridgeBio Oncology Therapeutics, Inc (BBOT) insider trading
Every open-market stock purchase and sale by BridgeBio Oncology Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.68 on Oct 21, 2026.
Recent BBOT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Yong Ben (Officer) | Sold (not open market) | $4.1K |
| Oct 1, 2026 | Pedro Beltran (CEO) | Sold (not open market) | $4.1K |
| Oct 1, 2026 | Idan Elmelech (COO) | Sold (not open market) | $1.4K |
| Oct 1, 2026 | Marc Cobo (Insider) | Sold (not open market) | $496 |
| Sep 10, 2026 | Marc Cobo (Insider) | Sold (not open market) | $1.1K |
| Sep 10, 2026 | Marc Cobo (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Marc Cobo (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Pedro Beltran (CEO) | Sold (not open market) | $8.2K |
| Jul 1, 2026 | Yong Ben (Officer) | Sold (not open market) | $8.2K |
| Jul 1, 2026 | Idan Elmelech (COO) | Sold (not open market) | $2.7K |
| Jul 1, 2026 | Marc Cobo (Insider) | Sold (not open market) | $975 |
| Jul 1, 2026 | Bihua Chen (10% owner) | Bought (not open market) | — |
| Jul 1, 2026 | Bihua Chen (10% owner) | Bought (not open market) | — |
| Jul 1, 2026 | Bihua Chen (10% owner) | Sold (not open market) | — |
| Jul 1, 2026 | Bihua Chen (10% owner) | Bought (not open market) | — |
| Jun 16, 2026 | Bihua Chen (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Jake Bauer (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Neil Kumar (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Raymond J. Kelleher (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Peter F Lebowitz (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Frank McCormick (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Praveen P. Tipirneni (Insider) | Bought (not open market) | — |
| May 10, 2026 | Pedro Beltran (CEO) | Bought (not open market) | — |
| May 10, 2026 | Idan Elmelech (COO) | Bought (not open market) | — |
| Apr 1, 2026 | Pedro Beltran (CEO) | Sold (not open market) | $9.5K |
Who's trading BBOT
- Marc Cobo, Insider: other filings, last Oct 1, 2026
- Pedro Beltran, CEO: other filings, last Oct 1, 2026
- Yong Ben, Officer: other filings, last Oct 1, 2026
- Idan Elmelech, COO: other filings, last Oct 1, 2026
- Bihua Chen, 10% owner: other filings, last Jul 1, 2026
- Jake Bauer, Insider: other filings, last Jun 16, 2026
- Raymond J. Kelleher, Insider: other filings, last Jun 16, 2026
- Neil Kumar, Insider: other filings, last Jun 16, 2026
- Peter F Lebowitz, Insider: other filings, last Jun 16, 2026
- Frank McCormick, Insider: other filings, last Jun 16, 2026
- Praveen P. Tipirneni, Insider: other filings, last Jun 16, 2026
- Uneek Mehra, CFO: other filings, last Apr 1, 2026
- Eli M. Wallace, CEO: other filings, last Jan 1, 2026
Get free alerts when an insider at BridgeBio Oncology Therapeutics, Inc files a new trade →